Cargando…

Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis

BACKGROUND: A systematic review and meta-analysis was conducted to assess breast cancer (BC) outcomes among patients with early-stage hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) BC, receiving adjuvant endocrine therapy. METHODS: Randomized controlled tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvo, Elizabeth M., Ramirez, Abril Oliva, Cueto, Jenilee, Law, Ernest H., Situ, Aaron, Cameron, Chris, Samjoo, Imtiaz A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089079/
https://www.ncbi.nlm.nih.gov/pubmed/33677313
http://dx.doi.org/10.1016/j.breast.2021.02.009